Pharmaceutical Session

The pharmaceutical group will be made up of a mix of constituencies representing trade/industry, public health, S&T, finance, RECs and key global players in the industry. The group will reflect on the challenges to developing a competitive pharmaceutical industry in Africa and mechanisms to facilitate business partnerships, in particular in the local production of generics, which will include but are not limited to treating the three major pandemics in Sub-Saharan Africa, namely, HIV/AIDS, Tuberculosis and Malaria.  In terms of outputs, the participants will be informed about the endorsement of the Pharmaceutical Manufacturing Plan for Africa (PMPA).  The segment will serve as a forum for generics business players represented by some of the global players (from Brazil, India, China, Europe, South Africa, etc.) to interact with African investors and to share insights for accelerating production of generics in Africa. Issues relating to investments, technology transfer, innovation, R&D, contract manufacturing, etc. will be discussed.